mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
8e-18 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
9e-15 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
2e-14 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
1e-11 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-10 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-09 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
2e-09 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-09 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
4e-09 |